Literature DB >> 3510455

Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro.

D Mazier, S Mellouk, R L Beaudoin, B Texier, P Druilhe, W Hockmeyer, J Trosper, C Paul, Y Charoenvit, J Young.   

Abstract

Antibodies were raised in mice immunized with several recombinant and synthetic peptides of the circumsporozoite protein of Plasmodium falciparum. The antibodies were evaluated for protective activity in a human hepatocyte culture system. They exerted their protective effect against the parasite at three points: sporozoite attachment to the hepatocyte surface, entry, and subsequent intracellular development. Inhibition of attachment and entry were found to be related to the antibody titer against the authentic circumsporozoite protein on the sporozoite surface, especially when peptides were administered with alum or complete Freund's adjuvant. Even when invasion was not totally inhibited, the presence of abnormal trophozoites and a frequent inhibition of schizont development in long-term cultures suggested continued activity of antibodies at the intracellular level after sporozoite penetration had been completed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510455     DOI: 10.1126/science.3510455

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  34 in total

1.  Placental malaria diminishes development of antibody responses to Plasmodium falciparum epitopes in infants residing in an area of western Kenya where P. falciparum is endemic.

Authors:  Phillip Cullison Bonner; Zhiyong Zhou; Lisa B Mirel; John G Ayisi; Ya Ping Shi; Anna M van Eijk; Juliana A Otieno; Bernard L Nahlen; Richard W Steketee; Venkatachalam Udhayakumar
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

Review 2.  A pre-emptive strike against malaria's stealthy hepatic forms.

Authors:  Dominique Mazier; Laurent Rénia; Georges Snounou
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

3.  Predicted conformations for the immunodominant region of the circumsporozoite protein of the human malaria parasite Plasmodium falciparum.

Authors:  K D Gibson; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.

Authors:  L D Lise; D Mazier; M Jolivet; F Audibert; L Chedid; D Schlesinger
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  A protective protein antigen of Rickettsia rickettsii has tandemly repeated, near-identical sequences.

Authors:  B E Anderson; G A McDonald; D C Jones; R L Regnery
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

6.  Theoretically determined three-dimensional structure for the repeating tetrapeptide unit of the circumsporozoite coat protein of the malaria parasite Plasmodium falciparum.

Authors:  B R Brooks; R W Pastor; F W Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection.

Authors:  P Druilhe; O Pradier; J P Marc; F Miltgen; D Mazier; G Parent
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

Review 8.  Malaria diagnosis: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

9.  Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.

Authors:  B Wizel; R A Houghten; K C Parker; J E Coligan; P Church; D M Gordon; W R Ballou; S L Hoffman
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen.

Authors:  R L Richards; M D Hayre; W T Hockmeyer; C R Alving
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.